Febuxostat has been recently introduced in the market as an alternative urate-lowering drug. Its allergenic profile has not been fully outlined and the clinical management of hypersensitivity reactions is not standardized. We report 2 cases of hypersensitivity reactions to febuxostat and present a desensitization protocol.
Desensitization to febuxostat: report of two cases.
Di Paolo C;Rizzini FL;
2015-01-01
Abstract
Febuxostat has been recently introduced in the market as an alternative urate-lowering drug. Its allergenic profile has not been fully outlined and the clinical management of hypersensitivity reactions is not standardized. We report 2 cases of hypersensitivity reactions to febuxostat and present a desensitization protocol.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2015 JACI Pract 3 ,633 FEBUXOSTAT.pdf
solo utenti autorizzati
Tipologia:
Full Text
Licenza:
DRM non definito
Dimensione
87.37 kB
Formato
Adobe PDF
|
87.37 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
